VisVires New Protein (VVNP)

VisVires New Protein (VVNP) is rated 3 out of 5 in the category venture capital & private equity. Read and write reviews about VisVires New Protein (VVNP). Since its inception in late 2013, VisVires New Protein (VVNP) has established itself as pioneer investors exclusively focused on finding disruptive solutions for our global food and feed system. Based in Singapore, VVNP has raised a US$ 40 million for its debut fund and employs a disciplined investment approach built on identifying existing global problems within the value-chain through active engagements with a strong network of academia and industry experts. Unrestricted by geographical boundaries, VVNP strives to uncover game-changing solutions and technologies that can be applied globally, especially to Asia. VVNP has made several investments including, among others, Ynsect in France, Ireland-based Nuritas, Mitte in Berlin and In Ovo in the Netherlands.